Do we need new chemosensitive experimental models?ATASSI, G.European journal of cancer & clinical oncology. 1984, Vol 20, Num 10, pp 1217-1220, issn 0277-5379Article

INVESTIGATIONS INTO THE ANTITUMOUR ACTIVITY OF ORGANOTIN COMPOUNDS. I: DIORGANOTIN DIHALIDE AND DI-PSEUDOHALIDE COMPLEXESCROWE AJ; SMITH PJ; ATASSI G et al.1980; CHEM. BIOL. INTERACT.; ISSN 0009-2797; NLD; DA. 1980; VOL. 32; NO 1-2; PP. 171-178; BIBL. 24 REF.Article

INFLUENCE OF ANTI-MICROCOCCUS IMMUNOGLOBULINS ON THE PROLIFERATION OF NORMAL IMMUNOCOMPETENT CELLS IN INBRED MICEVERLOES R; ATASSI G; KANAREK L et al.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 11; PP. 965-974; BIBL. 2 P.Article

POTENTIATION OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA BY AMPHOTERICIN B IN MURINE EPENDYMOBLASTOMA.LAURENT G; ATASSI G; HILDEBRAND J et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 11 PART. 1; PP. 4069-4073; BIBL. 20 REF.Article

COMPARISON BETWEEN THE IN VITRO INTERACTION OF LECTINS (PHA AND CONA) AND ANTIMICROCOCCUS ANTIBODIES ON NORMAL AND MALIGNANT CELLSVERLOES R; ATASSI G; KANAREK L et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 12; PP. 1439-1448; BIBL. 36 REF.Article

ANTITUMOUR IMMUNOPROTECTION BY AN IMMUNOBACTERIAL LECTIN APPROACH.VERLOES R; KANAREK L; ATASSI G et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 11; PP. 877-888; BIBL. 1 P. 1/2Article

COMPARISON OF ADRIAMYCIN WITH DNA-ADRIAMYCIN COMPLEX IN CHEMOTHERAPY OF EXPERIMENTAL TUMORS AND METASTASES = COMPARAISON DE L'ADRIAMYCINE ET DU COMPLEX ADN-ADRIAMYCINE DANS LA CHIMIOTHERAPIE DES TUMEURS EXPERIMENTALES ET DES METASTASESATASSI G; DUARTE KARIM M; TAGNON HJ et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 5; PP. 309-316; BIBL. 7REF.Serial Issue

POTENTIATION OF THE ANTITUMOR ACTIVITY OF 2-FORMYLPYRIDINE THIOSEMICARBAZONE BY METAL CHELATION: 2-FORMYLPYRIDINE THIOSEMICARBAZONE ZINC SULPHATE (NSC 294721)ATASSI G; DUMONT P; HARTEEL JCE et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 4; PP. 451-459; BIBL. 18 REF.Article

ABSENCE OF ANTITUMOR ACTIVITY OF ORG 5895, A 11BETA -AZIRIDINYLMETHYL DERIVATIVE OF ESTRADIOL, ON THE MXT MAMMARY TUMOR AND THE P388 LEUKEMIADEVLEESCHOUWER N; LECLERCQ G; DANGUY A et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 3; PP. 315-316; BIBL. 6 REF.Article

COMPARISON BETWEEN THE EFFECTS OF MICROCOCCUS, BCG AND RELATED POLYSACCHARIDES IN PRECLINICAL CHEMO-IMMUNOTHERAPY OF MURINE L1210 LEUKAEMIAVERLOES R; ATASSI G; DUMONT P et al.1978; ARCH. INTERNATION. PHYSIOL. BIOCHIM.; BEL; DA. 1978; VOL. 86; NO 4; PP. 969-971; BIBL. 1 REF.Article

COMPARISON OF MICROCOCCUS, BCG AND RELATED POLYSACCHARIDES IN THE SPECIFIC AND NON-SPECIFIC IMMUNE RESISTANCE TO MURINE L1210 LEUKEMIA.VERLOES R; ATASSI G; DUMONT P et al.1978; ARCH. INTERNATION. PHYSIOL. BIOCHIM.; BEL; DA. 1978; VOL. 86; NO 2; PP. 466-468; BIBL. 3 REF.Article

ANTITUMORAL EFFECT IN MICE OF A NEW TRIEPOXYDE DERIVATIVE: 1,3,5-TRIGLYCIDYL-5-TRIAZINETRIONE (NSC 296934)ATASSI G; SPREAFICO F; DUMONT P et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 12; PP. 1561-1567; BIBL. 11 REF.Article

TUMOR IMMUNOPROPHYLAXIS EXERTED BY THE ANTIMICROCOCCUS IMMUNITY. II: INFLUENCE ON THE PROLIFERATION OF MURINE PLASMACYTOMA (MOPC 173) AND EHRLICH CARCINOMA CELLSVERLOES R; ATASSI G; DUMONT P et al.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 12; PP. 1321-1329; BIBL. 25 REF.Article

SUCCESSFUL IMMUNOTHERAPY WITH MICROCOCCUS, BCG OR RELATED POLYSACCHARIDES ON L1210 LEUKAEMIA AFTER BCNU CHEMOTHERAPYVERLOES R; ATASSI G; DUMONT P et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 43; NO 2; PP. 201-209; BIBL. 25 REF.Article

PHASE I CLINICAL TRIAL WITH ALPHA 1,3,5-TRIGLYCIDYL-S-TRIAZINETRIONE (NSC-296934)PICCART M; ROZENCWEIG M; DODION P et al.1981; EUR. J. CANCER CLIN. ONCOL.; GBR; DA. 1981; VOL. 17; NO 12; PP. 1263-1266; BIBL. 13 REF.Article

CHEMOTHERAPEUTIC EFFICACY OF NOCODAZOLE ENCAPSULATED IN LIPOSOMES ON L1210 MURINE LEUKEMIA = EFFICACITE THERAPEUTIQUE DU NOCODAZOLE ENCAPSULE DANS LES LIPOSOMES SUR LA LEUCEMIE MURINE L1210LADURON C; COUNE A; ATASSI G et al.1983; RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY; ISSN 0034-5164; USA; DA. 1983; VOL. 39; NO 3; PP. 419-436; ABS. ENG; BIBL. 26 REF.; GRAPHArticle

THE ANTITUMOR ACTIVITY OF DIORGANOTIN (IV) COMPLEXES WITH ADENINE AND GLYCYLGLYCINEBARBIERI R; PELLERITO L; RUISI G et al.1982; INORG. CHIM. ACTA; ISSN 0020-1693; ITA; DA. 1982; VOL. 66; NO 3; PP. 39-40; BIBL. 8 REF.Article

A CHARACTERIZATION OF THE ACTIVITY OF ALPHA -1,3,5-TRIGLYCIDYL-S-TRIAZINETRIONE, A NOVEL ANTINEOPLASTIC COMPOUNDSPREAFICO F; ATASSI G; FILIPPESCHI S et al.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 5; NO 2; PP. 103-108; BIBL. 8 REF.Article

N-METHYLFORMAMIDE: ANTITUMOUR ACTIVITY AND METABOLISM IN MICEGESCHER A; GIBSON NW; HICKMAN JA et al.1982; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1982; VOL. 45; NO 6; PP. 843-850; BIBL. 26 REF.Article

Investigations into the antitumour activity of organotin compounds. II: Diorganotin dihalide and dipseudohalide complexesCROWE, A. J; SMITH, P. J; ATASSI, G et al.Inorganica chimica acta. 1984, Vol 93, Num 4, pp 179-184, issn 0020-1693Article

Eriochrome black T inhibits endothelial cell growth through S-phase blockadeLANGER, I; ATASSI, G; ROBBERECHT, P et al.European journal of pharmacology. 2000, Vol 399, Num 2-3, pp 85-90, issn 0014-2999Article

Flow cytometric evaluation of multidrug-resistance circumventionLEONCE, S; PIERRE, A; ATASSI, G et al.Bulletin du cancer. 1995, Vol 82, Num 2, pp 114-116, issn 0007-4551Article

Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumorsDUBOIS, J; ATASSI, G; HANOCQ, M et al.Cancer chemotherapy and pharmacology. 1988, Vol 22, Num 4, pp 282-288, issn 0344-5704Article

Characterization of the activity of α/β-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compoundATASSI, G; DUMONT, P; VANHAELEN, C et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 9, pp 1187-1191, issn 0277-5379Article

Development and characterization of a new murine renal tumor model: chemotherapeutic resultsVANDENDRIS, M; DUMONT, P; HEIMANN, R et al.Cancer chemotherapy and pharmacology. 1983, Vol 11, Num 3, pp 182-187, issn 0344-5704Article